Vor Biopharma Inc. (VOR)
NASDAQ: VOR · IEX Real-Time Price · USD
0.923
+0.006 (0.69%)
At close: Jul 19, 2024, 4:00 PM
0.976
+0.053 (5.70%)
Pre-market: Jul 22, 2024, 8:55 AM EDT
Vor Biopharma Employees
Vor Biopharma had 168 employees as of December 31, 2023. The number of employees increased by 35 or 26.32% compared to the previous year.
Employees
168
Change (1Y)
35
Growth (1Y)
26.32%
Revenue / Employee
n/a
Profits / Employee
-$715,679
Market Cap
63.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Prenetics Global | 324 |
| HOOKIPA Pharma | 179 |
| Allakos | 131 |
| ProPhase Labs | 113 |
| InspireMD | 66 |
| Entera Bio | 18 |
| Milestone Scientific | 17 |
| SELLAS Life Sciences Group | 16 |
VOR News
- 12 days ago - Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - Vor Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors - GlobeNewsWire
- 4 months ago - Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update - GlobeNewsWire
- 5 months ago - Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 months ago - Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit - GlobeNewsWire